In conditions in which you could have to have use of a medically-important drug for a significant or everyday living-threatening situation where there is absolutely no market approved drug readily available in copyright and for which alternate regular therapies have failed or are unsuitable, Health copyright's Specific Access Programme (SAP) is ava